Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 19, 2010

TriLink to Provide Affymetrix with Oligonucleotides

  • TriLink BioTechnologies will provide Affymetrix with oligonucleotides for use in its genetic analysis kits. The multiyear arrangement covers distribution and supply.

    Affymetrix technology is used by pharmaceutical, diagnostic, and biotechnology companies as well as academic, government, and nonprofit research institutes. More than 1,900 systems have been shipped around the world and more than 21,000 peer-reviewed papers have been published using the technology, the firm reports. It is headquartered in Santa Clara, CA, and has manufacturing facilities in Cleveland, OH, and Singapore. The company also maintains sales and distribution operations across Europe and Asia.

    Founded in 1996, TriLink is a privately held firm based in San Diego. It manufactures custom oligonucleotides, modified nucleoside triphosphates, and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research services, and ISO/QSR-compliant cGMP production facilities are offered.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »